All Relations between gh and insulin

Publication Sentence Publish Date Extraction Date Species
A Mimura, S Kageyama, K Itoh, J Miura, H Kurata, J Yokoyama, Y Iked. [Role of growth hormone in the pathogenesis of dawn phenomenon in IDDM]. Nihon Naibunpi Gakkai zasshi. vol 68. issue 6. 1992-08-25. PMID:1633930. in order to reassess the role of the nocturnal gh secretion in the dawn phenomenon, seven c-peptide negative diabetic patients were studied during 48hr-feedback control using a closed-loop insulin infusion device (biostator). 1992-08-25 2023-08-11 Not clear
A Mimura, S Kageyama, K Itoh, J Miura, H Kurata, J Yokoyama, Y Iked. [Role of growth hormone in the pathogenesis of dawn phenomenon in IDDM]. Nihon Naibunpi Gakkai zasshi. vol 68. issue 6. 1992-08-25. PMID:1633930. they received oral sleeping medication only on the first night (control) and sleeping medication with anticholinergic agent (pirenzepine 75mg) on the second night, and blood glucose, insulin requirements, gh and cortisol concentrations during 0000hr and 0700hr were measured. 1992-08-25 2023-08-11 Not clear
H P Koppeschaar, C D ten Horn, J H Thijssen, M D Page, C Dieguez, M F Scanlo. Differential effects of arginine on growth hormone releasing hormone and insulin induced growth hormone secretion. Clinical endocrinology. vol 36. issue 5. 1992-08-03. PMID:1617799. we wished to investigate the interaction of arginine, ghrh and insulin stress on gh secretion. 1992-08-03 2023-08-11 Not clear
J R Ward, D M Henricks, T C Jenkins, W C Bridge. Serum hormone and metabolite concentrations in fasted young bulls and steers. Domestic animal endocrinology. vol 9. issue 2. 1992-07-31. PMID:1617961. the effect of dietary energy restriction on serum insulin, insulin-like growth factor i (igf-i), growth hormone, (gh), cortisol, plasma urea nitrogen (pun) and nonesterified fatty acid (nefa) concentrations was examined. 1992-07-31 2023-08-11 Not clear
J R Ward, D M Henricks, T C Jenkins, W C Bridge. Serum hormone and metabolite concentrations in fasted young bulls and steers. Domestic animal endocrinology. vol 9. issue 2. 1992-07-31. PMID:1617961. serum was assayed for insulin, igf-i, gh, and cortisol (total and free). 1992-07-31 2023-08-11 Not clear
M Rosenbaum, J M Gertner, N Gidfar, J Hirsch, R L Leibe. Effects of systemic growth hormone (GH) administration on regional adipose tissue in children with non-GH-deficient short stature. The Journal of clinical endocrinology and metabolism. vol 75. issue 1. 1992-07-31. PMID:1619004. we found that gh therapy was associated with a significant reduction in abdominal adipocyte size (0.48 microgram +/- 0.08 lipid per cell prior to therapy vs. 0.43 microgram +/- 0.08 lipid per cell after therapy, p less than 0.05) and a significant increase in responsiveness of gluteal sc adipose tissue to the lipogenic actions of insulin. 1992-07-31 2023-08-11 human
M Rosenbaum, J M Gertner, N Gidfar, J Hirsch, R L Leibe. Effects of systemic growth hormone (GH) administration on regional adipose tissue in children with non-GH-deficient short stature. The Journal of clinical endocrinology and metabolism. vol 75. issue 1. 1992-07-31. PMID:1619004. the significant correlations of changes in abdominal adipocyte volume with changes in regional adipose tissue insulin sensitivity that were noted in gh-deficient children were not noted in this subject population, perhaps due to effects of endogenous gh on pretreatment insulin responsiveness of adipose tissue. 1992-07-31 2023-08-11 human
N E Felsing, J A Brasel, D M Coope. Effect of low and high intensity exercise on circulating growth hormone in men. The Journal of clinical endocrinology and metabolism. vol 75. issue 1. 1992-07-31. PMID:1619005. gas exchange (breath-by-breath), gh, immunoreactive insulin, glucose, lactate, pyruvate, and epinephrine and norepinephrine were measured at regular intervals. 1992-07-31 2023-08-11 human
D R Clemmons, A Smith-Banks, L E Underwoo. Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor-I in humans. The Journal of clinical endocrinology and metabolism. vol 75. issue 1. 1992-07-31. PMID:1619015. despite these differences in blood glucose, igf-i infusions decreased serum insulin (74.9 +/- 26.8 pmol/l on diet alone, to 16.7 +/- 1.5 pmol/l during igf-i) and serum connecting-peptide concentrations (2.14 +/- 0.89 mmol/l on diet alone, to 0.97 +/- 0.14 during igf-i), while gh raised insulin (109.4 +/- 31.3 pmol/l, p less than 0.05 during gh) and connecting-peptide (3.12 +/- 0.59 mmol/l, p less than 0.02). 1992-07-31 2023-08-11 human
A Rodriguez, E del Pozo, M D Rodriguez-Arnao, A Gómez-Pa. Growth progression and 24-hour hormone profile in an infant treated chronically with a long-acting somatostatin derivative. Hormone research. vol 35. issue 6. 1992-07-30. PMID:1687892. a 24-hour hormone profile recorded at the end of the observation period revealed the following: (1) failure to improve blood glucose with carbohydrate-enriched food due to reactive hyperinsulinemia; (2) hyperglycemic reaction after administration of sandostatin caused by a reduction of plasma insulin; this effect was particularly marked during sleep; (3) low mean gh, decreased spiking frequency and reduced area covered by the nocturnal peaks by recognized standards, and (4) normal somatomedin c levels for age. 1992-07-30 2023-08-11 Not clear
A Flyvbjerg, J Frystyk, R Osterby, H Orsko. Kidney IGF-I and renal hypertrophy in GH-deficient diabetic dwarf rats. The American journal of physiology. vol 262. issue 6 Pt 1. 1992-07-29. PMID:1616029. diabetic dwarf rats treated with human gh (hgh) or insulin and diabetic rats with intact pituitary were used as controls. 1992-07-29 2023-08-11 human
M E Thompson, W E Zimmer, A L Haynes, D L Valentine, S Forss-Petter, J G Scammel. Prolactin granulogenesis is associated with increased secretogranin expression and aggregation in the Golgi apparatus of GH4C1 cells. Endocrinology. vol 131. issue 1. 1992-07-27. PMID:1612012. gh cells were treated for up to 3 days with 17 beta-estradiol (1 nm), insulin (300 nm), and epidermal growth factor (10 nm) and were fixed in 4% paraformaldehyde for immunocytochemistry or harvested for rna isolation and northern blot analysis. 1992-07-27 2023-08-11 Not clear
D A Fryburg, R J Louard, K E Gerow, R A Gelfand, E J Barret. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes. vol 41. issue 4. 1992-07-23. PMID:1607069. we examined the effects of a combined, local intra-arterial infusion of growth hormone (gh) and insulin on forearm glucose and protein metabolism in seven normal adults. 1992-07-23 2023-08-11 Not clear
D A Fryburg, R J Louard, K E Gerow, R A Gelfand, E J Barret. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes. vol 41. issue 4. 1992-07-23. PMID:1607069. gh was infused into the brachial artery for 6 h with a dose that, in a previous study, stimulated muscle protein synthesis (phenylalanine rd) without affecting systemic gh, insulin, or insulinlike growth factor i concentrations. 1992-07-23 2023-08-11 Not clear
D A Fryburg, R J Louard, K E Gerow, R A Gelfand, E J Barret. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes. vol 41. issue 4. 1992-07-23. PMID:1607069. for the last 3 h of the gh infusion, insulin was coinfused with a dose that, in the absence of infused gh, suppressed forearm muscle proteolysis by 30-40% without affecting systemic insulin levels. 1992-07-23 2023-08-11 Not clear
D A Fryburg, R J Louard, K E Gerow, R A Gelfand, E J Barret. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes. vol 41. issue 4. 1992-07-23. PMID:1607069. glucose uptake by forearm tissues in response to gh and insulin did not change significantly between 3 and 6 h. by 6 h, the combined infusion of gh and insulin promoted a significantly more positive net balance of phenylalanine, leucine, isoleucine, and valine (all p less than 0.05). 1992-07-23 2023-08-11 Not clear
D A Fryburg, R J Louard, K E Gerow, R A Gelfand, E J Barret. Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin's antiproteolytic action in humans. Diabetes. vol 41. issue 4. 1992-07-23. PMID:1607069. the stimulation of rd, in the absence of an observed effect on ra, suggests that gh blunts the action of insulin to suppress proteolysis in addition to blunting insulin's action on rd. 1992-07-23 2023-08-11 Not clear
J D Teale, W F Blum, V Mark. Alleviation of non-islet cell tumour hypoglycaemia by growth hormone therapy is associated with changes in IGF binding protein-3. Annals of clinical biochemistry. vol 29 ( Pt 3). 1992-07-22. PMID:1376980. growth hormone (gh) secretion is almost invariably depressed as is the plasma insulin response to oral glucose. 1992-07-22 2023-08-11 Not clear
J D Teale, W F Blum, V Mark. Alleviation of non-islet cell tumour hypoglycaemia by growth hormone therapy is associated with changes in IGF binding protein-3. Annals of clinical biochemistry. vol 29 ( Pt 3). 1992-07-22. PMID:1376980. treatment with biosynthetic gh restored igfbp-3 to levels which were approximately equimolar to total plasma igf concentrations, alleviated the hypoglycaemia and restored the plasma insulin responses to oral glucose. 1992-07-22 2023-08-11 Not clear
C G Scane. Lipolytic and diabetogenic effects of native and biosynthetic growth hormone in the chicken: a re-evaluation. Comparative biochemistry and physiology. Comparative physiology. vol 101. issue 4. 1992-07-21. PMID:1351464. further evidence for a lack of a diabetogenic role for gh comes from the inability of chronic administration of gh to influence the decline in plasma concentrations of glucose following challenge with the insulin secretagogue, tolabutamide. 1992-07-21 2023-08-11 chicken